Printer Friendly

US BD launches short peripheral IV catheter.

M2 PHARMA-September 21, 2011-US BD launches short peripheral IV catheter(C)2011 M2 COMMUNICATIONS

21 September 2010 - US medical technology company BD announced today that it had launched through its unit BD Medical a short peripheral IV catheter (SPIVC) made to keep healthcare workers safe from needlestick injuries and blood exposure.

It is called BD insyte autoguard bc with blood control technology, which minimises blood exposure during insertion.

According to a recently published study, it cuts down the risk of mucocutaneous blood exposure by 95%, compared to a non-blood control IV catheter. Mucocutaneous exposure refers to blood or body fluid exposure to the mucous membrane of the eyes, nose, mouth or the skin.

The blood control technology is also designed to reduce contamination of work surfaces with pathogens, from where they could be transferred to medical staff and patients.

((Comments on this story may be sent to

COPYRIGHT 2011 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 Pharma
Date:Sep 21, 2011
Previous Article:TranS1 announces common stock offering.
Next Article:GI Dynamics launches endobarrier in Austria, opens new centers.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters